Crystal's Coder Hub👁️ ICD-10 CM H35.00 — Unspecified Background Retinopathy
Billable Code Confirmed
ICD-10 CM H35.00 is a valid, fully billable 5-character ICD-10-CM code effective for dates of service from October 1, 2015 through the current FY2026 edition (effective October 1, 2025). The code structure is: H (Diseases of the Eye) + 35 (Other retinal disorders) + .0 (Background retinopathy subcategory) + 0 (Unspecified type). As a 5-character code it satisfies the minimum specificity requirement for claims submission; however, H35.00 carries a critical qualifier — CMS has flagged it as a Questionable As Admission Diagnosis (QAAD), meaning its use as a principal inpatient diagnosis will draw payer and utilization review scrutiny and should be avoided unless no more appropriate PDx is available.
Non-Billable Parent Codes
H35 (Other retinal disorders) is a non-billable header/parent code covering all non-diabetic retinal disorders not classified elsewhere; it requires additional characters before becoming billable and must never appear on a claim. H35.0 (Background retinopathy and retinal vascular changes) was a valid billable code through FY2024 but was converted to a non-billable parent code in FY2025 when the subcategory was expanded; it now requires a mandatory 5th character specifying the type of background retinopathy and must not be submitted for reimbursement in FY2025 or FY2026. Submitting either parent code will result in rejection or denial at most payers.
Clinical Context
ICD-10 CM H35.00 is the code of last resort within the H35.0 subcategory — appropriate only when provider documentation confirms the presence of background (non-proliferative, non-diabetic) retinopathy but does not specify the type or the laterality. In the vast majority of clinical encounters, more specific sibling codes are available and preferred: H35.031–H35.039 for hypertensive retinopathy, H35.011–H35.019 for changes in retinal vascular appearance, H35.041–H35.049 for micro-aneurysms, and similar series for exudative retinopathy, neovascularization, vasculitis, and telangiectasis. When diabetic retinopathy is the documented cause, the appropriate E08–E13 combination code series must be used in place of any H35.0x code — the Excludes2 at H35 permits dual coding only when a truly distinct, non-diabetic retinopathy is separately documented alongside a diabetic one.
Code Classification
ICD-10 CM H35.00 is an ICD-10-CM diagnosis code within Chapter 7, Diseases of the Eye and Adnexa (H00–H59). It classifies a clinical finding — retinal microvascular pathology of unspecified type — rather than a procedure. In the inpatient facility setting, it may function as a secondary diagnosis complicating an admission for another condition (hypertensive urgency, autoimmune disease, systemic vascular disease); its use as a principal diagnosis is flagged as QAAD and should be approached with caution and clinical documentation support. It is not an etiology/manifestation pair, a complication code, or a sequela code.
🔍 Code Description
ICD-10 CM H35.00 — Unspecified Background Retinopathy describes a pathological condition of the retinal microvasculature in which early-stage, non-proliferative vascular changes are present but the clinical documentation does not specify the type of retinopathy or the affected eye(s). In its broadest clinical meaning, “background retinopathy” encompasses the earliest visible microvascular abnormalities of the retina: microaneurysms (focal outpouchings of capillary walls), dot-and-blot hemorrhages (intraretinal hemorrhages from microaneurysm rupture), hard exudates (lipid deposits from leaking vessels), soft exudates or cotton-wool spots (nerve fiber layer ischemia), and arteriolar changes such as narrowing, AV nicking, or copper/silver wiring reflecting chronic hypertensive remodeling. These changes reflect microvascular damage from systemic conditions — most commonly hypertension, but also radiation exposure, collagen vascular disease, hematologic disorders, and rarely medication toxicity (such as hydroxychloroquine). Unlike proliferative retinopathy, background retinopathy has not yet advanced to neovascularization — the pathologic growth of fragile new blood vessels onto the retinal surface or into the vitreous — and therefore carries a different clinical risk profile, monitoring strategy, and treatment pathway.1,2
The term “background retinopathy” originated in diabetic retinopathy staging to describe mild non-proliferative diabetic retinopathy (NPDR); however, in ICD-10-CM the H35.0x family is explicitly excluded from diabetic retinopathy coding. When any type 1, type 2, drug-induced, or secondary diabetic retinopathy is documented, coders must select from the E08–E13 combination code series (Excludes2 at H35), which incorporate both the diabetes type and retinopathy severity into a single combination code. The H35.0x codes — and specifically H35.00 — are reserved for non-diabetic background retinopathy only. When hypertension is the documented cause or association, a Code Also instruction at H35.0 directs the coder to additionally report I10 (Essential [primary] hypertension). From a CDI standpoint, every encounter coded with H35.00 should prompt a provider query for: (1) the specific type of retinal vascular change, (2) the laterality of involvement, and (3) whether hypertension or another systemic etiology is a contributing cause — all elements typically present in a complete ophthalmology examination report — to allow assignment of a more specific, defensible code from the H35.0x sibling family.3,4
🌳 Code Tree / Hierarchy
H00–H59 Diseases of the Eye and Adnexa ❌ Non-billable
│
└── H30–H36 Disorders of Choroid and Retina ❌ Non-billable
│
└── H35 Other Retinal Disorders ❌ Non-billable
│
├── H35.0 Background Retinopathy and Retinal Vascular Changes ❌ Non-billable
│ │ (converted to parent code FY2025; was billable through FY2024)
│ │
│ ├── ▶▶ H35.00 ◀◀ Unspecified Background Retinopathy ← YOU ARE HERE ✅ Billable ⚠️ QAAD
│ │
│ ├── H35.011 Changes in Retinal Vascular Appearance, Right Eye ✅ Billable
│ ├── H35.012 Changes in Retinal Vascular Appearance, Left Eye ✅ Billable
│ ├── H35.013 Changes in Retinal Vascular Appearance, Bilateral ✅ Billable
│ ├── H35.019 Changes in Retinal Vascular Appearance, Unspecified Eye ✅ Billable
│ │
│ ├── H35.021 Exudative Retinopathy, Right Eye ✅ Billable
│ ├── H35.022 Exudative Retinopathy, Left Eye ✅ Billable
│ ├── H35.023 Exudative Retinopathy, Bilateral ✅ Billable
│ ├── H35.029 Exudative Retinopathy, Unspecified Eye ✅ Billable
│ │
│ ├── H35.031 Hypertensive Retinopathy, Right Eye ✅ Billable
│ ├── H35.032 Hypertensive Retinopathy, Left Eye ✅ Billable
│ ├── H35.033 Hypertensive Retinopathy, Bilateral ✅ Billable
│ ├── H35.039 Hypertensive Retinopathy, Unspecified Eye ✅ Billable
│ │
│ ├── H35.041 Retinal Micro-Aneurysms, Unspecified, Right Eye ✅ Billable
│ ├── H35.042 Retinal Micro-Aneurysms, Unspecified, Left Eye ✅ Billable
│ ├── H35.043 Retinal Micro-Aneurysms, Unspecified, Bilateral ✅ Billable
│ ├── H35.049 Retinal Micro-Aneurysms, Unspecified, Unspecified Eye ✅ Billable
│ │
│ ├── H35.051 Retinal Neovascularization, Unspecified, Right Eye ✅ Billable
│ ├── H35.052 Retinal Neovascularization, Unspecified, Left Eye ✅ Billable
│ ├── H35.053 Retinal Neovascularization, Unspecified, Bilateral ✅ Billable
│ ├── H35.059 Retinal Neovascularization, Unspecified, Unspecified Eye ✅ Billable
│ │
│ ├── H35.061 Retinal Vasculitis, Right Eye ✅ Billable
│ ├── H35.062 Retinal Vasculitis, Left Eye ✅ Billable
│ ├── H35.063 Retinal Vasculitis, Bilateral ✅ Billable
│ ├── H35.069 Retinal Vasculitis, Unspecified Eye ✅ Billable
│ │
│ ├── H35.071 Retinal Telangiectasis, Right Eye ✅ Billable
│ ├── H35.072 Retinal Telangiectasis, Left Eye ✅ Billable
│ ├── H35.073 Retinal Telangiectasis, Bilateral ✅ Billable
│ ├── H35.079 Retinal Telangiectasis, Unspecified Eye ✅ Billable
│ │
│ └── H35.09 Other Intraretinal Microvascular Abnormalities ✅ Billable
│
├── H35.1 Retinopathy of Prematurity ❌ Non-billable (subcategory)
├── H35.2 Other Non-Diabetic Proliferative Retinopathy ❌ Non-billable (subcategory)
├── H35.3 Degeneration of Macula and Posterior Pole ❌ Non-billable (subcategory)
└── H35.7 Separation of Retinal Layers ❌ Non-billable (subcategory)
QAAD Flag — Inpatient Principal Diagnosis Risk
ICD-10 CM H35.00 is flagged as a Questionable As Admission Diagnosis (QAAD) by CMS in the Medicare Code Edits file. When assigned as the principal diagnosis for an inpatient stay, this code may not independently justify medical necessity for hospital-level care, and MACs routinely screen QAAD-coded cases during post-payment review. Background retinopathy alone does not typically require inpatient admission; when H35.00 appears as PDx, the coder should review the encounter thoroughly for a clinically stronger principal diagnosis or initiate a CDI query before finalizing.
No Laterality Axis — Unique Among H35.0x Siblings
Unlike all other sibling codes in the H35.0x family (H35.011–H35.079), which require a 6th character for laterality (1 = right, 2 = left, 3 = bilateral, 9 = unspecified), H35.00 has no laterality axis — it ends at 5 characters and is inherently unspecified for both type and side. This means H35.00 is appropriate only when both the type of background retinopathy AND the laterality are absent from documentation. If the provider documents laterality but not the specific type (or vice versa), a CDI query is still indicated; the “unspecified eye” variants (e.g., H35.019, H35.039) may be more appropriate than H35.00 when the type is specified but laterality is not.
✅ Includes
- Background retinopathy, not otherwise specified (NOS) — Applicable when documentation confirms retinal vascular changes consistent with background retinopathy but does not specify the subtype (hypertensive, exudative, vascular appearance changes, micro-aneurysms, etc.).
- Retinopathy unspecified type, non-diabetic context — When the provider documents “retinopathy” or “background retinopathy” without further qualification and no diabetes mellitus is established as the causative factor.
- Acute zonal occult outer retinopathy (AZOOR) — Per ICD-10-CM Alphabetic Index references, AZOOR maps to H35.00 in the absence of a more specific retinal dystrophy or inflammatory retinopathy code.
- Retinal vascular changes, unspecified — When documentation reflects global retinal vascular changes without identifying the dominant pathological finding or the affected eye(s).
- Hydroxychloroquine retinopathy, unspecified type (per index) — The ICD-10-CM Alphabetic Index routes some hydroxychloroquine-associated retinal toxicity presentations to H35.00 as a default; an adverse effect code from the T36–T65 series must also be reported per adverse effect coding guidelines.
❌ Excludes
Excludes 1
There are no Excludes 1 notes directly at the H35.00 code level. No mutually exclusive conditions are defined at this code that prevent simultaneous reporting.
Most Common Excludes-Related Error — Diabetic Retinopathy
The most consequential exclusion error at the H35 family level is assigning H35.00 to a patient whose “background retinopathy” is diabetic in etiology. The Excludes2 annotation at H35 for the E08–E13 retinal disorder range creates a persistent misconception: coders sometimes apply H35.00 as the retinopathy code in a diabetic patient, then add the diabetes E-code separately. This is incorrect. When diabetic retinopathy is documented, the manifestation must be captured in the combination code within the diabetes chapter (e.g., E11.319 for type 2 DM with unspecified diabetic retinopathy without macular edema). H35.00 may only accompany a diabetes E-code when the patient has a documented non-diabetic retinopathy that is distinct from and coexisting with the diabetic retinopathy.
Excludes 2
Excludes2 notes at H35 (apply to H35.00 through annotation back-reference). These conditions may be coded simultaneously only when both conditions are separately and distinctly documented:
- E08.311–E08.359 — Diabetes mellitus due to underlying condition with retinal disorders: use the E08.3xx combination code series when retinopathy is attributable to secondary diabetes. Dual coding with [[H35.00]] is appropriate only when a truly separate non-diabetic retinopathy is also documented.
- E09.311–E09.359 — Drug or chemical induced diabetes mellitus with retinal disorders: use E09.3xx series for drug-induced diabetic retinopathy; H35.00 is not a substitute.
- E10.311–E10.359 — Type 1 diabetes mellitus with retinal disorders: always use the E10.3xx combination code series for type 1 diabetic retinopathy; do not substitute H35.00.
- E11.311–E11.359 — Type 2 diabetes mellitus with retinal disorders: most common scenario; use the E11.3xx series for any retinopathy confirmed as diabetic in etiology. H35.00 is appropriate alongside only if a separate, independently documented non-diabetic retinopathy is present.
- E13.311–E13.359 — Other specified diabetes mellitus with retinal disorders: same exclusion logic applies as above.
📋 Clinical Overview
Background vs. Specific Retinopathy — Selecting Among H35.0x Siblings
Understanding when H35.00 is appropriate versus a more specific sibling requires evaluating two axes in the provider’s documentation: (1) the type of retinal vascular change identified on fundoscopic or imaging examination, and (2) the laterality of involvement. Both axes must be absent from documentation to justify H35.00; the presence of either axis — even without the other — should trigger a provider query rather than automatic default to the unspecified code.
| Feature | H35.00 | H35.031 | H35.011 |
|---|---|---|---|
| Full Description | Unspecified background retinopathy | Hypertensive retinopathy, right eye | Changes in retinal vascular appearance, right eye |
| Laterality | No laterality axis — inherently unspecified for both type and side | Right eye specified (6th character = 1) | Right eye specified (6th character = 1) |
| Clinical Driver | Documentation states only “background retinopathy” without further qualification | Hypertensive etiology explicitly documented + right eye specified | Arteriolar narrowing, AV nicking, or vessel caliber change documented in right eye |
| Code Also Required? | Code Also I10 per H35.0 parent annotation if hypertension is documented | Yes — Code Also I10 per H35.0 parent instruction | Code Also I10 if hypertension is the documented driving cause |
| DRG Impact | DRG 124/125; QAAD flag creates PDx scrutiny | DRG 124/125; more specific code supports medical necessity documentation | DRG 124/125; laterality-specific code reduces audit risk |
| HCC Mapping | ❌ Not HCC-mapped | ❌ Not HCC-mapped | ❌ Not HCC-mapped |
| CDI/Query Priority | High — query for type and laterality before finalizing | Low — all required specificity elements captured | Low — all required specificity elements captured |
CDI Trigger — H35.00 Should Always Prompt a Query
Any encounter coded with H35.00 represents a near-certain documentation gap in the vast majority of clinical situations. Ophthalmology documentation almost universally specifies the type of retinal change (e.g., “hypertensive retinopathy,” “micro-aneurysms,” “retinal vascular changes”) and laterality (right, left, or bilateral) within the body of the examination report, even when the assessment/plan is vague. When detailed findings exist in the chart but were not carried into the assessment, H35.00 represents a documentation capture failure rather than a true “unspecified” condition. CDI specialists should query for: (1) specific type of retinal vascular change, (2) laterality of the finding, and (3) whether hypertension or another systemic condition is the documented cause, to trigger the Code Also I10 instruction and allow assignment of a more defensible sibling code.
Manifestations & Symptom Burden
- Microaneurysms — Focal, dot-like outpouchings of retinal capillary walls; the earliest clinically visible sign of microvascular disease; typically asymptomatic in isolation; specifically coded as H35.041–H35.049 when documented as the dominant finding.
- Hard exudates — Lipid deposits in the outer retinal layers leaking from microaneurysms; appear as bright yellow-white deposits on fundoscopy; associated with risk of macular thickening when concentrated in the macular region.
- Dot-and-blot hemorrhages — Small intraretinal hemorrhages from microaneurysm rupture confined to the inner nuclear and outer plexiform layers; typically asymptomatic but indicate active capillary disease.
- Cotton-wool spots (soft exudates) — Fluffy white patches representing nerve fiber layer ischemia; more prominently associated with hypertensive or embolic retinopathy; their presence alongside hard exudates suggests mixed capillary and arteriolar disease.
- Arteriolar changes (AV nicking, copper/silver wiring) — Visible narrowing, increased arterial light reflex, or arteriovenous crossing changes reflecting chronic hypertensive arteriolar remodeling; specifically coded as H35.011–H35.019 when documented as the dominant finding.
Manifestation Coding for Retinopathy
Individual background retinopathy manifestations (microaneurysms, exudates, hemorrhages) do not receive separate ICD-10-CM codes in most encounters — they are clinically included within the retinopathy diagnosis code itself. Retinal edema, when separately and explicitly documented as a distinct complication beyond the retinopathy description, may be additionally reported as H35.81 (Retinal edema). In the diabetic retinopathy setting, macular edema is captured within the E-code combination code structure (e.g., E11.311 for type 2 DM with unspecified diabetic retinopathy with macular edema) and should not be separately coded with [[H35.81]] in those encounters.
💰 HCC Risk Adjustment
| Field | Value |
|---|---|
| HCC Category (V28) | ❌ N/A — Not mapped to any HCC |
| RAF Value | $0.000 — No risk adjustment contribution |
| HCC Model | CMS-HCC V28 (implemented 2024) |
| Condition Status | Non-chronic risk category / insufficient specificity for HCC mapping |
| Annual Recapture Required? | N/A |
| MA Plan Impact | None — does not support risk score or premium calculation |
ICD-10 CM H35.00 does not map to any hierarchical condition category in the CMS-HCC V28 model and contributes no RAF score to Medicare Advantage risk calculations, ACA marketplace HCC programs, or PACE program risk scoring.5 Conditions carrying HCC weight in the retinal disease space are mapped through the diabetic retinopathy combination codes (E10.3x–E13.3x series), which may trigger HCC capture via their diabetes parent categories. For inpatient CDI programs focused on HCC capture, H35.00 is not a target code and should not be queried for risk adjustment value; however, improving its specificity to identify the underlying systemic driver (such as ensuring hypertension is fully documented and coded with I10) may indirectly support capture of other HCC-mapped comorbidities present in the encounter.
🏥 MS-DRG Assignment
| Field | Value |
|---|---|
| MDC | MDC 02 — Diseases and Disorders of the Eye |
| DRG (with MCC) | DRG 124 — Other Disorders of the Eye with MCC or Thrombolytic Agent |
| DRG (with CC only) | N/A — 2-tier family; no separate CC-specific DRG |
| DRG (without CC/MCC) | DRG 125 — Other Disorders of the Eye without MCC |
| DRG Tier Structure | 2-tier (MCC only): DRG 124 vs. DRG 125 |
| QAAD Status | ⚠️ Yes — Questionable As Admission Diagnosis (CMS MCE v43.1) |
| POA Exempt | No — POA indicator required on inpatient claims |
ICD-10 CM H35.00 groups to MDC 02 (Diseases and Disorders of the Eye) and the DRG 124/125 pair under MS-DRG v43.0 (FY2026).3 This family uses a simplified 2-tier MCC-only structure — DRG 124 when a qualifying MCC (such as respiratory failure, sepsis, or other listed comorbidity) is present, DRG 125 otherwise; there is no separate CC-tier DRG in this family. Because H35.00 carries a QAAD flag per CMS Medicare Code Edits, its assignment as the principal diagnosis subjects the claim to payer review and MAC audit scrutiny, as hospital-level care driven solely by background retinopathy is not clinically expected or supported by payer guidelines. In practice, H35.00 almost always appears as a secondary diagnosis during admissions where another acute condition — hypertensive urgency, uncontrolled diabetes, or systemic vascular emergency — drives the principal diagnosis and DRG assignment. As a secondary diagnosis, H35.00 does not independently shift the DRG pair but contributes to documentation completeness and clinical complexity narratives. Coders should evaluate whether a more specific sibling code (e.g., H35.033 for bilateral hypertensive retinopathy) is documentable before finalizing H35.00 as the secondary retinopathy code.
🔗 Related ICD-10-CM Codes
H35.0x Sibling Codes — Preferred Over H35.00 When Specificity Is Documentable
| Code | Description |
|---|---|
| H35.011 | Changes in retinal vascular appearance, right eye |
| H35.012 | Changes in retinal vascular appearance, left eye |
| H35.013 | Changes in retinal vascular appearance, bilateral |
| H35.019 | Changes in retinal vascular appearance, unspecified eye |
| H35.031 | Hypertensive retinopathy, right eye |
| H35.032 | Hypertensive retinopathy, left eye |
| H35.033 | Hypertensive retinopathy, bilateral |
| H35.039 | Hypertensive retinopathy, unspecified eye |
| H35.041 | Retinal micro-aneurysms, unspecified, right eye |
| H35.042 | Retinal micro-aneurysms, unspecified, left eye |
| H35.043 | Retinal micro-aneurysms, unspecified, bilateral |
| H35.049 | Retinal micro-aneurysms, unspecified, unspecified eye |
| H35.051 | Retinal neovascularization, unspecified, right eye |
| H35.052 | Retinal neovascularization, unspecified, left eye |
| H35.053 | Retinal neovascularization, unspecified, bilateral |
| H35.059 | Retinal neovascularization, unspecified, unspecified eye |
| H35.061 | Retinal vasculitis, right eye |
| H35.062 | Retinal vasculitis, left eye |
| H35.063 | Retinal vasculitis, bilateral |
| H35.069 | Retinal vasculitis, unspecified eye |
| H35.09 | Other intraretinal microvascular abnormalities |
Diabetic Retinopathy Alternatives — Use Instead of H35.00 When Diabetes Is the Etiology
| Code | Description |
|---|---|
| E11.319 | Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema |
| E11.311 | Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema |
| E10.319 | Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema |
| E10.311 | Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema |
Code Also / Associated Conditions
| Code | Description |
|---|---|
| I10 | Essential (primary) hypertension — Code Also at H35.0 subcategory level when hypertension is associated |
| H35.81 | Retinal edema — additionally reportable when separately and explicitly documented as a distinct complication beyond the retinopathy itself |
🛠️ Commonly Associated CPT Codes
| CPT Code | Description | Billing Notes |
|---|---|---|
| 92250 | Fundus photography with interpretation and report, bilateral | Most common diagnostic code paired with H35.00 in the outpatient/office setting for documentation of retinal vascular findings; requires both image capture and a documented interpretation/report |
| 92228 | Remote imaging for monitoring of retinal disease (teleophthalmology) | Used in store-and-forward teleophthalmology and diabetic eye screening programs; H35.00 is a valid indication; verify payer coverage criteria for remote retinal imaging |
| 92235 | Fluorescein angiography (FA) with interpretation and report, unilateral or bilateral | Ordered when background retinopathy findings warrant characterization of leakage patterns or capillary non-perfusion; H35.00 is a valid indication; payers may require documentation of medical necessity beyond routine screening |
| 92134 | Scanning computerized ophthalmic diagnostic imaging, posterior segment — retina (OCT) | Optical coherence tomography of the posterior segment; increasingly used for baseline and serial monitoring in retinopathy; H35.00 supports medical necessity for initial and monitoring imaging; requires interpretation and report |
| 67228 | Treatment of extensive or progressive retinopathy (e.g., panretinal photocoagulation) | Applicable when retinopathy has progressed to a stage requiring scatter laser; H35.00 is unlikely to be the primary diagnosis at this stage — a more specific code (e.g., H35.051–H35.053 for neovascularization) would typically serve as PDx |
| 67210 | Destruction of localized lesion of retina, photocoagulation | For focal laser treatment of localized retinal lesions (e.g., micro-aneurysm leakage threatening the macula); H35.00 may appear as a secondary diagnosis when background retinopathy accompanies the treated lesion |
NCCI Bundling Considerations
92235 (fluorescein angiography) and 92250 (fundus photography) performed on the same date are subject to NCCI edits — most payers bundle fundus photography payment into the FA when both are performed in the same encounter, as the imaging is considered clinically redundant. 92228 (remote imaging) and 92134 (OCT-retina) may also trigger bundling edits when billed alongside other posterior segment imaging codes on the same date of service. Coders should verify current NCCI edits and payer-specific policies before billing multiple ophthalmic imaging codes in conjunction with H35.00 or its sibling codes; modifier -59 or XS/XE modifiers may be required to document distinct, separately ordered, and independently interpreted services when bundling edits are triggered. The clinical note should explicitly document each imaging study as separately medically necessary to withstand audit review.
🔬 ICD-10-PCS Crosswalk
Note
ICD-10 CM H35.00 as a non-surgical diagnosis will rarely drive an ICD-10-PCS procedure code directly. In the inpatient setting, PCS codes are assigned for therapeutic or diagnostic procedures performed during the admission — not for the diagnosis itself. If background retinopathy is a secondary diagnosis during an admission for hypertensive urgency or uncontrolled diabetes, no PCS procedure code for the retinal condition is expected unless a therapeutic retinal intervention is performed. Root operation selection depends on technique: Destruction (5) applies to laser photocoagulation of retinal vessels; Introduction (in the Administration section) applies to intravitreal injections. Verify all PCS codes against the FY2026 ICD-10-PCS tables before assignment — PCS body part character values for the Eye body system should be confirmed in the current published tables.7
| PCS Code | Full Description | Applicable Procedure |
|---|---|---|
085EXZZ | Destruction of Retinal Vessel, Right, External Approach, No Device, No Qualifier | Laser photocoagulation of retinal vessels, right eye (panretinal or focal) — verify body part character E against current PCS tables |
085FXZZ | Destruction of Retinal Vessel, Left, External Approach, No Device, No Qualifier | Laser photocoagulation of retinal vessels, left eye — verify body part character F |
3E0C3GC | Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach, Other Substance | Intravitreal injection (e.g., anti-VEGF: bevacizumab, ranibizumab, aflibercept) — verify substance characters against FY2026 Administration section tables |
08J0XZZ | Inspection of Right Eye, External Approach, No Device, No Qualifier | Fundoscopic examination / indirect ophthalmoscopy, right eye |
08J1XZZ | Inspection of Left Eye, External Approach, No Device, No Qualifier | Fundoscopic examination / indirect ophthalmoscopy, left eye |
PCS Character Analysis — 085EXZZ
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 8 | Eye |
| 3 | Root Operation | 5 | Destruction — physical eradication of all or a portion of a body part by direct use of energy, force, or a destructive agent; no body part is taken out |
| 4 | Body Part | E | Retinal Vessel, Right (verify against FY2026 PCS tables) |
| 5 | Approach | X | External — procedures performed directly on skin or mucous membrane, or through a natural or artificial body opening without incision (includes transscleral/transpupillary laser photocoagulation) |
| 6 | Device | Z | No Device |
| 7 | Qualifier | Z | No Qualifier |
PCS Root Operation: Destruction (5) vs. Repair (Q)
- Use Destruction (5) when the primary intent of the retinal laser procedure is to ablate, coagulate, or eradicate diseased or abnormal retinal vessels or lesions (e.g., panretinal scatter photocoagulation for neovascularization, focal laser for leaking micro-aneurysms threatening the macula).
- Use Repair (Q) when the primary intent is to restore normal anatomical structure or function without eradicating tissue — rare in the context of background retinopathy.
- For bilateral retinal laser performed in the same operative session, assign separate PCS code lines for each eye — PCS has no modifier equivalent for bilateral procedures; each eye is coded independently.
💊 Coding Scenarios and Examples
Scenario 1 — Outpatient Ophthalmology: Unspecified Background Retinopathy, No Laterality Documented
Clinical Scenario: A 64-year-old male with a history of essential hypertension and hyperlipidemia presents to ophthalmology for a follow-up examination. Fundus photography reveals scattered dot-and-blot hemorrhages and mild arteriolar narrowing. The provider’s assessment states: “Background retinopathy — will monitor.” No laterality is specified in the assessment or plan. No further characterization of the type of vascular change is documented beyond “background retinopathy.” No separate, significant E/M service is documented beyond the routine ophthalmic exam.
| Field | Code | Rationale |
|---|---|---|
| PDx | H35.00 | Provider documented “background retinopathy” without specifying type or laterality; H35.00 is appropriate as a last resort; CDI query for type and laterality is indicated |
| SDx | I10 | Essential hypertension is a documented comorbidity; per Code Also instruction at H35.0, I10 is additionally reported when hypertension is associated with retinal vascular changes |
Note
This scenario represents the most common — and most correctable — use of H35.00. The fundus photography findings (dot-and-blot hemorrhages, arteriolar narrowing) in a hypertensive patient strongly suggest hypertensive retinopathy (H35.031–H35.039); however, the assessment does not specify this, and laterality is absent. A CDI query to the provider seeking clarification of (1) the specific type of retinal change and (2) laterality would allow assignment of a more specific code. Until queried and clarified, H35.00 + I10 represents the most defensible coding supported by the documentation as written.
Scenario 2 — Inpatient: Secondary Diagnosis During Hypertensive Urgency Admission
Clinical Scenario: A 72-year-old female is admitted for hypertensive urgency with a presenting blood pressure of 218/118. Ophthalmology is consulted inpatient and performs indirect ophthalmoscopy. The ophthalmology consult note documents: “Background retinopathy present bilaterally — no disc edema, no neovascularization noted. Recommend outpatient monitoring.” Laterality (bilateral) is specified in the consult note, but the type of retinopathy is not characterized beyond “background retinopathy.” The patient is managed with IV antihypertensives and discharged on day 2.
| Field | Code | Rationale |
|---|---|---|
| PDx | I10 | Hypertensive urgency is the principal diagnosis driving the admission; I10 covers essential hypertension in all presentations; H35.00 must not be used as PDx given QAAD status |
| SDx | H35.00 | Background retinopathy bilateral is documented; laterality is specified but type is not; H35.00 is used pending query — H35.033 (bilateral) would be appropriate if hypertensive retinopathy is confirmed by provider |
Warning
Do NOT assign H35.00 as the principal diagnosis — the QAAD flag and clinical presentation both require I10 as the correct PDx. A CDI query to the consulting ophthalmologist is indicated: given the admission for hypertensive urgency and bilateral retinal findings, clarifying “background retinopathy bilateral” as “hypertensive retinopathy bilateral” would support assignment of H35.033 — a more clinically accurate code that also satisfies the Code Also instruction for I10 automatically. The bilateral laterality is documented in the consult note and should not be lost in the final code assignment.
Scenario 3 — Inpatient: Mandatory CDI Query — Diabetic vs. Hypertensive vs. Unspecified Retinopathy
Clinical Scenario: A 68-year-old male with type 2 diabetes mellitus (uncontrolled) and essential hypertension is admitted for cellulitis of the right lower extremity. The attending physician’s problem list documents “background retinopathy” without specifying etiology, laterality, or type. The coder must determine whether this represents diabetic retinopathy (coded through E11.319 or other E11.31x code), hypertensive retinopathy (H35.031–H35.039), or non-specific background retinopathy (H35.00) before finalizing the secondary code list. No ophthalmology consult is documented.
| Field | Code | Rationale |
|---|---|---|
| PDx | L03.115 | Cellulitis of right lower limb — principal diagnosis driving the admission |
| SDx — Pending Query | H35.00 (interim placeholder only) | Cannot finalize retinopathy code without provider clarification of etiology; H35.00 is a placeholder pending query resolution |
| SDx | E11.65 | Type 2 diabetes mellitus with hyperglycemia — separately reportable comorbidity contributing to the clinical complexity of the admission |
| SDx | I10 | Essential (primary) hypertension — additionally reportable; also functions as the Code Also requirement at H35.0 if retinopathy is confirmed as hypertensive |
Note
This is a mandatory query scenario. The coder must query the attending physician before finalizing the retinopathy code: (1) Is the “background retinopathy” in this patient attributable to diabetic retinopathy → use E11.319 or other specific E11.31x code; (2) Is it hypertensive retinopathy → use H35.039 or a laterality-specific variant; (3) Is it an unrelated non-diabetic, non-hypertensive retinopathy → H35.00 or more specific sibling. Assigning H35.00 without this query is a coding compliance risk — it may represent a missed diabetes combination code (E11.319), which carries different clinical documentation, quality metric, and program reporting implications. The final retinopathy code selection hinges entirely on provider query response.
⚠️ Coding Pitfalls and Tips
-
Using H35.00 when a diabetic retinopathy combination code is required: The most frequent and consequential error with H35.00 is assigning it to a patient whose documented “background retinopathy” is diabetic in etiology. The Excludes2 at H35 does not mean “code both” in a diabetic patient with retinopathy — it means the diabetic retinopathy must be captured in the E08–E13 combination code series (e.g., E11.319). Only if the patient has a second, independently documented non-diabetic retinopathy may both codes be reported simultaneously. Failure to use the diabetes combination code represents an incorrect code selection, a potential missed quality indicator, and — when the diabetes code carries HCC weight through its parent category — a risk adjustment gap.
-
Omitting the Code Also instruction for I10: The H35.0 subcategory carries a Code Also instruction to report any associated hypertension with I10, and this instruction travels to H35.00 through annotation back-reference. When a hypertensive patient is coded with H35.00, I10 must appear on the claim or encounter as an additional diagnosis. Omitting I10 when hypertension is documented leaves the clinical picture incomplete and represents an inaccurate secondary diagnosis list — particularly consequential in the inpatient setting where secondary diagnosis completeness affects DRG defensibility and quality metric compliance.
-
Assigning H35.00 as the inpatient principal diagnosis without addressing QAAD status: H35.00 is flagged as a Questionable As Admission Diagnosis (QAAD) by CMS in the MCE. Using it as PDx without a documented compelling clinical rationale for hospital-level care — or without reviewing the encounter for a more appropriate principal diagnosis — exposes the claim to payer denial, MAC post-payment audit, and recoupment. Background retinopathy alone does not require inpatient admission; when it appears as PDx in a claim, it almost always reflects a sequencing error or a documentation capture failure that should be resolved through query or reassignment.
-
Defaulting to H35.00 when laterality is documented in the body of the note: Many coders default to H35.00 upon seeing “background retinopathy” in the assessment, even when the ophthalmology examination documents right eye, left eye, or bilateral involvement in the clinical findings. H35.00 has no laterality axis — the sibling codes capture laterality via their 6th character. If the provider’s note specifies the affected eye anywhere in the encounter (even in the exam findings rather than the assessment), that laterality information should drive code selection toward the appropriate sibling. Assigning H35.00 when a laterality-specific code is supported by documentation constitutes a specificity failure that may be cited as an inaccurate code selection on audit.
-
Confusing H35.00 (Unspecified) with H35.09 (Other): When the provider documents a specific but uncommon retinal microvascular finding not captured in the H35.01x–H35.07x named subtypes — such as intraretinal microvascular abnormalities (IRMA) — H35.09 (Other intraretinal microvascular abnormalities) is the more appropriate code. H35.09 captures named-but-unlisted specific findings; H35.00 captures truly unspecified background retinopathy where no type can be determined. Selecting H35.00 when the provider has identified a specific finding that maps to H35.09 understates the documentation and misrepresents the clinical picture.
-
Failing to initiate a CDI query every time H35.00 is assigned: H35.00 is a valid but inherently low-specificity code, and its presence in a code assignment should function as an automatic CDI trigger in any facility with a query program. Every assignment of H35.00 should prompt the question: does the clinical documentation actually support “unspecified” for both type and laterality, or is there sufficient clinical detail elsewhere in the chart to support a more specific code? In the inpatient setting particularly, this query discipline directly supports documentation integrity, secondary diagnosis accuracy, and preparation for payer audit.